NCT06646757Completed
Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability
Source: ClinicalTrials.gov · Last updated 9 Jan 2026
Brief summary (registry, in English)
EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combination of four multimodal behavioral interventions to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy. The interventions are four existing, publicly available disease-specific self-help resources offered at no cost to the participants: a book, smart app, help center, and peer mentor. Participants will complete online surveys and may engage in virtual focus groups. Participants may receive an honorarium (e-gift card) and/or be entered into a lottery for a giftcards post-survey completion and focus group participation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 803 (actual)
- First submitted
- 21 Aug 2024
- Start date
- 14 Aug 2024
- Primary completion date
- 15 Oct 2025
- Lead sponsor
- University of Pennsylvania
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06646757
What you commit to
- Study type: Interventional
- Participants enrolled: 803
- From 14 Aug 2024 to the primary completion date, 15 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No/low disability (IBD-DI \< 35) on the baseline survey
- Inability or unwillingness to participate in the interventions
- Inability to download apps from the Apple AppStore or Google Play store (necessary to engage with the smartapp intervention)
- Limited English proficiency (necessary because some interventions are currently only offered in English)
Who the study is looking for
- Adults (age ≥ 18 years) with IBD and moderate-to-severe IBD-related (IBD) Disability Index score \> 35 26,27)
- Able to consent, complete surveys, and participate in focus groups in English.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.